At A Glance
Name: Ron Eisenwinter
Title: Consultant on FDA and regulatory issues, Boston Healthcare Associates-Expertech
Background: BS in cell biology and biochemistry from Boston University.
Steven Gutman’s July 8 letter to the chief of Roche Diagnostics is “pivotal,” and will set the tone for the way in which the agency views ASRs and other molecular diagnostics, according to many industry experts.